Cargando…

Clinical characteristics and prognosis of osteosarcoma in young children: a retrospective series of 15 cases

BACKGROUND: Osteosarcoma is the most common primary bone malignancy in childhood and adolescence. However, it is very rare in children under 5 years of age. Although studies in young children are limited in number, they all underline the high rate of amputation in this population, with conflicting r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guillon, Maud AM, Mary, Pierre MJ, Brugière, Laurence, Marec-Bérard, Perrine, Pacquement, Hélène D, Schmitt, Claudine, Guinebretière, Jean-Marc, Tabone, Marie-Dominique P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3188515/ https://www.ncbi.nlm.nih.gov/pubmed/21942935 http://dx.doi.org/10.1186/1471-2407-11-407

Ejemplares similares

High Dose Thiotepa in Patients with Relapsed or Refractory Osteosarcomas: Experience of the SFCE Group
por: Marec-Berard, Perrine, et al.
Publicado: (2014)

Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study
por: Tabone, Marie-Dominique, et al.
Publicado: (2017)

Genetic alterations in primary osteosarcoma from 54 children and adolescents by targeted allelotyping
por: Entz-Werle, N, et al.
Publicado: (2003)

Successive Osteosarcoma Relapses after the First Line O2006/Sarcome-09 Trial: What Can We Learn for Further Phase-II Trials?
por: Thebault, Eric, et al.
Publicado: (2021)

Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC’S (Observatoire de l’Utilisation des Thérapies Ciblées dans les Sarcomes)
por: Penel-Page, Mathilde, et al.
Publicado: (2015)

Thymus and Mediastinal Node Involvement in Childhood Langerhans Cell Histiocytosis: Long-Term Follow-Up From the French National Cohort
por: Ducassou, Stephane, et al.
Publicado: (2013)

Late toxicity comparison of alkylating‐based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro‐EWING99‐R1 in France
por: Corvest, Victoria, et al.
Publicado: (2022)

Characterization of Macrophages and Osteoclasts in the Osteosarcoma Tumor Microenvironment at Diagnosis: New Perspective for Osteosarcoma Treatment?
por: Gomez-Brouchet, Anne, et al.
Publicado: (2021)

Solitary Fibrous Tumors and So-Called Hemangiopericytoma
por: Penel, Nicolas, et al.
Publicado: (2012)

Prognosis of osteosarcomas in the mandible: 15-year experience of 55 patients
por: Seng, Dongjie, et al.
Publicado: (2019)

Desmoplastic Small Round Cell Tumor: Current Management and Recent Findings
por: Dufresne, Armelle, et al.
Publicado: (2012)

Percutaneous Core Needle Biopsy Can Efficiently and Safely Diagnose Most Primary Bone Tumors
por: Crenn, Vincent, et al.
Publicado: (2021)

Ewing’s Sarcoma of the Head and Neck: Margins are not just for surgeons
por: Bouaoud, Jebrane, et al.
Publicado: (2018)

A positioning pillow to improve lumbar puncture success rate in paediatric haematology-oncology patients: a randomized controlled trial
por: Marec-Bérard, Perrine, et al.
Publicado: (2009)

High-dose chemotherapy followed by whole lung irradiation in pulmonary relapse Ewing’s sarcomas: a retrospective multicenter study
por: Duverge, Loig, et al.
Publicado: (2022)

P02-16 Implementation of a program based on adapted physical activity and recommendations for second cancers prevention for adolescents and young adults with cancer: PREVAPAJA study
por: Mongondry, Rodolf, et al.
Publicado: (2022)

Bone Sarcomas: From Biology to Targeted Therapies
por: Gaspar, Nathalie, et al.
Publicado: (2012)

The Relationship between PBLS and Osteosarcoma Distribution in Different Subgroups and the Survival and Prognosis of Osteosarcoma
por: Luo, Peng, et al.
Publicado: (2023)

Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)(☆)
por: Gaspar, N., et al.
Publicado: (2021)

Parental comprehension of the benefits/risks of first-line randomised clinical trials in children with solid tumours: a two-stage cross-sectional interview study
por: Chappuy, Hélène, et al.
Publicado: (2013)

TUFT1 Promotes Osteosarcoma Cell Proliferation and Predicts Poor Prognosis in Osteosarcoma Patients
por: Yu, Yao-Ping, et al.
Publicado: (2018)

Osteopontin as a biomarker for osteosarcoma therapy and prognosis
por: Han, Xingwen, et al.
Publicado: (2019)

Upregulation of 15 Antisense Long Non-Coding RNAs in Osteosarcoma
por: Rothzerg, Emel, et al.
Publicado: (2021)

Effect of Unplanned Therapy on the Prognosis of Patients with Extremity Osteosarcoma
por: Wang, Bing, et al.
Publicado: (2016)

Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma
por: Yang, Zuozhang, et al.
Publicado: (2016)

Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma
por: Fu, Yucheng, et al.
Publicado: (2018)

WNT6 is an effective marker for osteosarcoma diagnosis and prognosis
por: Jiang, Kai, et al.
Publicado: (2018)

Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
por: Hong, Weifeng, et al.
Publicado: (2020)

The relationship between the expression of Ki-67 and the prognosis of osteosarcoma
por: Zeng, Ming, et al.
Publicado: (2021)

SELPLG Expression Was Potentially Correlated With Metastasis and Prognosis of Osteosarcoma
por: Wang, Bingqi, et al.
Publicado: (2022)

The Immune Landscape of Osteosarcoma: Implications for Prognosis and Treatment Response
por: Cascini, Caterina, et al.
Publicado: (2021)

Comprehensive analysis of cuproptosis in immune response and prognosis of osteosarcoma
por: Li, Mingzhe, et al.
Publicado: (2022)

International randomised controlled trial for the treatment of newly diagnosed EWING sarcoma family of tumours – EURO EWING 2012 Protocol
por: Anderton, Jennifer, et al.
Publicado: (2020)

Polymorphisms of vascular endothelial growth factor on prognosis in osteosarcoma patients
por: Dong-ju, Zhao, et al.
Publicado: (2014)

Osteosarcoma: prognosis plateau warrants retinoblastoma pathway targeted therapy
por: Ballatori, Sarah E, et al.
Publicado: (2016)

CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma
por: Ma, Chao, et al.
Publicado: (2019)

High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients
por: Uzan, Vanessa Regina Maciel, et al.
Publicado: (2016)

EFEMP1 as a Potential Biomarker for Diagnosis and Prognosis of Osteosarcoma
por: Wang, Zhuo, et al.
Publicado: (2020)

RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma
por: Chen, Shijie, et al.
Publicado: (2022)

Correlation between Patient‐Derived Xenograft Modeling and Prognosis in Osteosarcoma
por: Sun, Mengxiong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_789dei1i54tirrcvi713q7dijh